Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

NCT01208662

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Comprehensive Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California at San Diego La Jolla, California, United States
View all 46 locations
View Trial Details
Active, not recruiting

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

NCT02718833

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
  • Newton-Wellesley Hospital Newton, Massachusetts, United States
View Trial Details
Active, not recruiting

Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

NCT03701308

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Community Cancer Institute Clovis, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 188 locations
View Trial Details
Active, not recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.

NCT06359002

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Het Ziekenhuisnetwerk Antwerpen Antwerp, Belgium
  • UZ Leuven Leuven, Belgium
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
  • Institut Catala d'Oncologia Badalona, Spain
View Trial Details
Active, not recruiting

A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT04586426

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
View all 40 locations
View Trial Details
Active, not recruiting

A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)

NCT03987958

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Meir Medical Center /ID# 213352 Kfar Saba, Central District, Israel
  • Assuta Tel Aviv Medical Center /ID# 213371 Tel Aviv, Central District, Israel
  • HaEmek Medical Center /ID# 213370 Afula, Haifa District, Israel
  • Shaare Zedek Medical Center /ID# 228016 Jerusalem, Israel
View Trial Details

Related conditions